Literature DB >> 10836279

Antigenic characterization of rabies virus isolates from vaccinated dogs in plateau state, Nigeria.

A E Okoh1.   

Abstract

Rabies isolates (genotype 1 lyssaviruses) from vaccinated dogs that died of rabies infection in the Plateau area of Nigeria were characterized using monoclonal antibodies (MAbs). The isolates were examined for rabies (genotype 1) and rabies-related (genotypes 2, 3 and 4) viruses by the indirect fluorescent antibody test carried out with MAb 502-2, which recognizes the nucleocapsid protein of all known lyssaviruses, and with MAb 422-5, which identifies only rabies-related viruses. All three isolates showed positive immunofluorescence with MAb 502-2 and were negative with MAb 422-5, indicating that they were all rabies (genotype 1) viruses. Characterization with a panel of 36 anti-nucleocapsid monoclonal antibodies showed that all three isolates reacted positively with 35 of the anti-nucleocapsid MAbs, including MAb 102-27 and MAb 377-7. Characterization using a panel of 44 anti-glycoprotein MAbs differentiated the isolates sharply from LEP Flury and PM vaccine viruses. The pattern of anti-glycoprotein reactivity of the isolates showed them to belong to one distinct viral subtype, except for a minor variation in one isolate that was not neutralized by MAb 1101-3. None of the three isolates was identified as the Flury low egg passage (LEP) vaccine strain used for vaccinating dogs in Nigeria. In fact, all the three isolates had the typical pattern of reactivity of isolates from unvaccinated dogs, including MASS 83, a rabies virus isolated in Nigeria and characterized at the Wister Institute before this study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836279     DOI: 10.1023/a:1006412516340

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  12 in total

1.  WHO Expert Committee on Rabies: sixth report.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1973

2.  Recovery from rabies. A case report.

Authors:  M A Hattwick; T T Weis; C J Stechschulte; G M Baer; M B Gregg
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

3.  Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein.

Authors:  A Flamand; T J Wiktor; H Koprowski
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

4.  [Antigenic variants among street rabies virus isolates from France, Africa, Madagascar and Asia. Preliminary results with antinucleocapsid monoclonal antibodies].

Authors:  P Sureau; P E Rollin
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1982       Impact factor: 2.268

5.  Viral zoonoses in Nigeria: (I) Rabies.

Authors:  O A Durojaiye
Journal:  Int J Zoonoses       Date:  1984-06

6.  Clinical rabies in three vaccinated dogs in Nigeria.

Authors:  A E Okoh
Journal:  Vet Rec       Date:  1983-07-02       Impact factor: 2.695

7.  Production and use of avianised rabies vaccine in Nigeria.

Authors:  D R Nawathe; I Banerjee; E N Okeke; J N Tiyagnet
Journal:  Int J Zoonoses       Date:  1981-06

8.  Hospital records of human rabies and antirabies prophylaxis in Nigeria 1969-78.

Authors:  A H Fagbami; V O Anosa; E O Ezebuiro
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

9.  Canine rabies in Nigeria, 1970 - 1980 reported cases in vaccinated dogs.

Authors:  A E Okoh
Journal:  Int J Zoonoses       Date:  1982-12

10.  Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. I. The nucleocapsid protein.

Authors:  A Flamand; T J Wiktor; H Koprowski
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

View more
  1 in total

1.  Antigenic variations of recent street rabies virus.

Authors:  Wenbo Wang; Jian Ma; Jianhui Nie; Jia Li; Shouchun Cao; Lan Wang; Chuanfei Yu; Weijin Huang; Yuhua Li; Yongxin Yu; Mifang Liang; Brett Zirkle; Xiaojiang S Chen; Xuguang Li; Wei Kong; Youchun Wang
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.